StonvexLoading…
StonvexStonvexStonvexCore line items from OSRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 |
|---|---|---|---|---|
Revenue | $1.90M | $761.27K | $1.79M | $910.23K |
Operating Income | $-8.15M | $-2.92M | $-6.51M | $-3.30M |
Net Income | $-16.62M | $-11.39M | $-97.30K | $-60.43K |
EPS (Diluted) | $-0.69 | $-1.04 | $-1.00 | $-0.01 |
Total Assets | $185.42M | $174.55M | $20.63M | $37.27M |
Total Liabilities | $46.26M | $42.27M | $5.49M | $4.82M |
Cash & Equivalents | $1.58M | $1.60M | $119.12K | $3.64K |
Free Cash Flow OCF − CapEx | $-549.36K | Not available | Not available | Not available |
Shares Outstanding | 19.81M | 19.28M | 2.15M | 2.15M |